NewEdge Advisors LLC Has $1.25 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

NewEdge Advisors LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,983 shares of the company’s stock after buying an additional 384 shares during the quarter. NewEdge Advisors LLC’s holdings in HealthEquity were worth $1,246,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Barclays PLC raised its stake in HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after purchasing an additional 112,667 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of HealthEquity in the third quarter valued at approximately $260,000. Wilmington Savings Fund Society FSB bought a new stake in shares of HealthEquity in the third quarter valued at approximately $150,000. Franklin Resources Inc. increased its stake in HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock worth $139,369,000 after acquiring an additional 11,659 shares during the period. Finally, GAMMA Investing LLC raised its holdings in HealthEquity by 32.9% in the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock valued at $120,000 after acquiring an additional 309 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on HQY. Barrington Research reissued an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group decreased their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price target for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 16th. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $111.75.

HealthEquity Trading Down 0.3 %

NASDAQ HQY opened at $85.83 on Friday. The company has a market cap of $7.42 billion, a price-to-earnings ratio of 78.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s fifty day moving average is $92.41 and its 200 day moving average is $96.39.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,381 shares of company stock worth $1,781,432. 2.20% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.